About Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia
Clinical Trials at Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia
During the past decade, Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Centro Servizi ANMCO S.r.l." with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "University Of Perugia" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia
According to Clinical.Site data, the most researched conditions in "Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia" are
"Atrial Fibrillation" (2 trials), "Breast Cancer" (2 trials), "Acute Coronary Syndromes" (1 trials), "Acute Pulmonary Embolism" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia" in a lesser frequency.
Clinical Trials Intervention Types at Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia
Most popular intervention types in "Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia" are "Drug" (3 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (3 trials), "Doxorubicin" (2 trials), "Paclitaxel" (2 trials), "Trastuzumab" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia
The vast majority of trials in "Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia" are
10 trials for "All" genders.
Clinical Trials Status at Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia
Currently, there are NaN active trials in "Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".